Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HSCT vs Intensive Insulin in Early Onset T1D
NCT01285934Phase 2Withdrawn
- Sponsor
- Northwestern University
- Start
- Jan 2009
- Primary completion
- Aug 2015
- Modality
- Stem Cell Therapies
01
Overview
A Phase 2 trial of autologous hematopoietic stem cells in type 1 diabetes mellitus (T1D), sponsored by Northwestern University. Planned start Jan 2009; status: withdrawn.
02
Drugs
autologous hematopoietic stem cells
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT01285934.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01285934.